A double-blind cross-over clinical trial of naftidrofuryl (‘Praxilene,’) is described in a group of 24 elderly subjects with severe intellectual impairment, using a simple psychometric test to assess mental function and behaviour. Significant improvement in intellectual function occurred with the drug and this effect was prolonged.